Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Extracellular Matrix01:42

The Extracellular Matrix

89.6K
Overview
89.6K
The Extracellular Matrix01:29

The Extracellular Matrix

12.5K
Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
12.5K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Extracellular Matrix01:26

Extracellular Matrix

5.6K
Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
5.6K
The Bone Matrix01:18

The Bone Matrix

5.9K
Bone contains a relatively small number of cells entrenched in a matrix of collagen fibers that provide an adherent surface for inorganic salt crystals. Both components of the matrix, organic and inorganic, contribute to the unusual properties of bone. Without collagen, bones would be brittle and shatter easily. Without mineral crystals, bones would flex and provide little support. This can be observed by an experiment: when the minerals of a bone are dissolved by soaking the bone in...
5.9K
Group Therapy01:26

Group Therapy

472
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
472

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial Cell Loss After Phacoemulsification in a Romanian Cohort: Early Outcomes and Associated Risk Factors.

Diagnostics (Basel, Switzerland)·2026
Same author

Surgical Management of Complicated Chronic Uveitis: A Case Report.

Romanian journal of ophthalmology·2025
Same author

A Case Series of Serious Adverse Events Following Anti-VEGF Intravitreal Injections.

Romanian journal of ophthalmology·2025
Same author

Short-term effects of antiglaucomatous topical medication on the ocular surface in Wistar rats.

Romanian journal of ophthalmology·2025
Same author

Objective Evaluation of Ocular Surface Adverse Effects in Patients Receiving Topical Antiglaucoma Treatment.

Romanian journal of ophthalmology·2025
Same author

The 79th Annual Meeting of the European Board of Ophthalmology, alongside the UEMS Meeting.

Romanian journal of ophthalmology·2024
Same journal

Neurofibromatosis Type 1 with Plexiform Neurofibroma: A Novel Mutation Uncovered.

Romanian journal of ophthalmology·2026
Same journal

Isolated Third Nerve Palsy and Alternate Hemiparesis in Brain Stem Stroke: A Case Report.

Romanian journal of ophthalmology·2026
Same journal

Innovations in Corneal Transplantation: The Role of Eye Banks, Donor Corneas, and Artificial Alternatives in Combating Worldwide Corneal Blindness.

Romanian journal of ophthalmology·2026
Same journal

Neural Network - Supported Prognostic Assessment of Apoptotic and Inflammatory Markers in Neovascular Glaucoma.

Romanian journal of ophthalmology·2026
Same journal

Visual Improvement and Optical Quality Changes After Keratoplasty in Macular Corneal Dystrophy in Romania.

Romanian journal of ophthalmology·2026
Same journal

Fat Infiltration in Eyelids: An Uncommon Clinical Case with Long-Term Monitoring.

Romanian journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Feb 14, 2026

Mechanical Micronization of Lipoaspirates for Regenerative Therapy
05:02

Mechanical Micronization of Lipoaspirates for Regenerative Therapy

Published on: March 15, 2019

8.2K

Matrix regenerative therapy.

Cristina-Mihaela Timaru1, Cornel Stefan1, Daniela Adriana Iliescu1

  • 1phthalmology Department, "Dr. Carol Davila" Central Military Emergency University Hospital, Bucharest, Romania.

Romanian Journal of Ophthalmology
|February 17, 2018
PubMed
Summary
This summary is machine-generated.

Regenerating agents (RGTA®), structural analogues of heparan sulfate (HS), promote ocular surface wound healing. These agents replace degraded HS in the extracellular matrix, aiding tissue regeneration and regulating healing in eye diseases.

Keywords:
RGTAextracellular matrixregenerating agentswound healing

More Related Videos

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.8K
Establishing Organoids from Human Tooth as a Powerful Tool Toward Mechanistic Research and Regenerative Therapy
11:02

Establishing Organoids from Human Tooth as a Powerful Tool Toward Mechanistic Research and Regenerative Therapy

Published on: April 13, 2022

4.2K

Related Experiment Videos

Last Updated: Feb 14, 2026

Mechanical Micronization of Lipoaspirates for Regenerative Therapy
05:02

Mechanical Micronization of Lipoaspirates for Regenerative Therapy

Published on: March 15, 2019

8.2K
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

Published on: October 4, 2017

10.8K
Establishing Organoids from Human Tooth as a Powerful Tool Toward Mechanistic Research and Regenerative Therapy
11:02

Establishing Organoids from Human Tooth as a Powerful Tool Toward Mechanistic Research and Regenerative Therapy

Published on: April 13, 2022

4.2K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Ophthalmology

Background:

  • The extracellular matrix (ECM) regulates crucial cell behaviors like proliferation, survival, migration, and differentiation.
  • Heparan sulfate (HS) is a key ECM component, vital for storing cell communication proteins essential for tissue regeneration.
  • Degraded HS in the ECM impairs cellular functions and tissue repair.

Purpose of the Study:

  • To evaluate the efficacy of Regenerating Agents (RGTA®) as bioengineered HS analogues in ophthalmology.
  • To investigate the role of RGTA® in improving ocular surface wound healing and matrix remodeling.
  • To understand how RGTA® regulates the wound healing process in various ocular conditions.

Main Methods:

  • Utilizing RGTA®, structural analogues of heparan sulfate glycosaminoglycans.
  • Applying RGTA® to address degraded endogenous HS in the ECM.
  • Investigating RGTA®'s effects in the context of ocular surface wound healing and matrix remodeling.

Main Results:

  • RGTA® effectively replaces degraded endogenous HS in the ECM.
  • RGTA® demonstrates potential in enhancing ocular surface wound healing.
  • RGTA® plays a regulatory role in the wound healing cascade within ocular tissues.

Conclusions:

  • RGTA® represents an innovative therapeutic strategy for ocular surface repair.
  • RGTA® facilitates improved matrix remodeling and controlled wound healing in ophthalmological applications.
  • The use of RGTA® holds promise for managing various ocular diseases characterized by impaired healing.